Obesity and prostate cancer - An ambiguous relationship

European Journal of Cancer

Volumn 43, Issue 7, 2007, Pages 1114-1116

  Augustin, Herbert ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; TESTOSTERONE;

ARTICLE; BODY MASS; CANCER RISK; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL;

EID: 34247153328     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.03.006     Document Type: Note

References (14)

1. Andersson S.O., Wolk A., Bergstrom R., et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 89 (1997) 385-389
2. Wright ME, Chang SC, Schatzkin A, et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007 [Epub ahead of print].
3. Giovannucci E., Rimm E.B., Stampfer M.J., Colditz G.A., and Willett W.C. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6 (1997) 557-563
4. Pasquali R., Casimirri F., Cantobelli S., et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40 (1991) 101-104
5. Strom S.S., Kamat A.M., Gruschkus S.K., et al. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 107 (2006) 631-639
6. Siddiqui S.A., Inman B.A., Sengupta S., et al. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer 107 (2006) 521-529
7. Amling C.L., Riffenburgh R.H., Sun L., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22 (2004) 439-445
8. D'Amico A.V., Chen M.H., Malkowicz S.B., et al. Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. J Urol 167 (2002) 2025-2030
9. Smith M.R. Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer. Clin Cancer Res 13 (2007) 241-245
10. Daniell H.W. A better prognosis for obese men with prostate cancer. J Urol 155 (1996) 220-225
11. Baillargeon J., Pollock B.H., Kristal A.R., et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103 (2005) 1092-1095
12. Werny D.M., Thompson T., Saraiya M., et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 16 (2007) 70-76
13. Freedland S.J., Platz E.A., Presti Jr. J.C., et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 175 (2006) 500-504
14. Hutterer G, Perrotte P, Gallina A, et al. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Eur J Cancer 2007 [in press].